Michelle Chen+FollowChikungunya Vaccine Drama in EuropeEurope just hit pause on Valneva’s new chikungunya vaccine for folks 65+ after some serious side effects popped up—including two deaths. The vaccine, which was supposed to protect against the mosquito-borne virus, is now under review. The company’s working with health authorities to figure out what’s going on, but for now, older adults are being told to skip it. Wild how fast things can change with new meds! #healthnews #vaccineupdate #chikungunya #Europe #Valneva #Health00Share
Adam Cox+FollowVaccine Pause After Scary Side EffectsFrench health officials just hit pause on Valneva’s new chikungunya vaccine for people 65+ after three hospitalizations and one death on La Reunion island. The shot’s still good for younger adults, but they’re investigating if it’s risky for seniors—especially those with health issues. The same vaccine’s under review in the US too. Wild how fast things can change with new meds! #VaccineNews #HealthUpdate #Chikungunya #Valneva #PharmaWatch #Health252109Share
